New Therapeutic Strategies in Retinal Vascular Diseases: A Lipid Target, Phosphatidylserine, and Annexin A5-A Future Theranostic Pairing in Ophthalmology
Despite progress in the management of patients with retinal vascular and degenerative diseases, there is still an unmet clinical need for safe and effective therapeutic options with novel mechanisms of action. Recent mechanistic insights into the pathogenesis of retinal diseases with a prominent vas...
Saved in:
Main Authors: | Anna Frostegård (Author), Anders Haegerstrand (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Annexin A5 Inhibits Endothelial Inflammation Induced by Lipopolysaccharide-Activated Platelets and Microvesicles via Phosphatidylserine Binding
by: Brent J. Tschirhart, et al.
Published: (2023) -
Ophthalmology: Current and Future Developments: Volume 2 - Diagnostic Atlas of Retinal Diseases
Published: (2017) -
Ophthalmology: Current and Future Developments: Volume 1 - Diagnostic Atlas of Retinal Diseases
Published: (2016) -
Ophthalmology: Current and Future Developments: Volume 3 - Diagnostic Atlas of Retinal Diseases
Published: (2017) -
Ophthalmology: Current and Future Developments: Volume 1 - Diagnostic Atlas of Retinal Diseases
Published: (2016)